|
Summary of clinical and pathological data of 79 tumor samples |
|||||
| A/A |
A/C |
AC/C |
C/C |
C/C(N+) |
|
|
|
|||||
| Tissue fraction analyzed |
Adenoma |
Adenoma |
Adenoma and carcinoma mixture |
Carcinoma |
Carcinoma |
|
|
|||||
| Tumor stage |
Adenoma |
Carcinoma |
Carcinoma |
Carcinoma |
Carcinoma |
|
|
|||||
| Treatment |
|||||
| TEM |
24 |
6 |
5 |
3 |
1 |
| TME |
4 |
3 |
2 |
20 |
11 |
|
|
|||||
| Sex (M/F) |
15/13 |
2/7 |
3/4 |
10/13 |
10/2 |
|
|
|||||
| Age (mean) |
69 |
71 |
64 |
66 |
62 |
|
|
|||||
| Dysplasia (adenoma) |
|||||
| Low |
15 |
||||
| high |
9 |
||||
|
|
|||||
| Stage (carcinoma) |
|||||
| T1 |
7 |
3 |
11 |
||
| T2 |
2 |
3 |
12 |
12 |
|
| T3 |
1 |
||||
|
|
|||||
| Size(cm) (mean) |
5.9 |
4.4 |
4.2 |
3.2 |
5.1 |
|
|
|||||
| Genomic data |
|||||
| Samples typed(n) |
21 |
8 |
7 |
19 |
11 |
| Abberations (%) |
|||||
| 1q23 gain |
0 |
9 |
11 |
14 |
62 |
| 8q22-24 gain |
9 |
18 |
44 |
50 |
62 |
| 13q gain |
4 |
36 |
67 |
59 |
85 |
| 17p loss |
17 |
18 |
44 |
91 |
62 |
| 18q12-22 loss |
17 |
36 |
56 |
86 |
77 |
| 20q gain |
17 |
27 |
78 |
86 |
92 |
Lips et al. BMC Cancer 2008 8:314 doi:10.1186/1471-2407-8-314 |
|||||